Pocket Versus Tunnel ICRS for Treatment of Keratoconus

Sponsor
Assiut University (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT05748847
Collaborator
(none)
62
1
2
46
1.3

Study Details

Study Description

Brief Summary

Keratoconus is a corneal degenerative disease associated with loss of best-corrected visual acuity. The use of intrastromal corneal ring segment implants is indicated to regularize the cornea and to reduce aberrations.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Intrastromal corneal ring segment implantation (Pocket)
  • Procedure: Intrastromal corneal ring segment implantation (Tunnel)
N/A

Detailed Description

Keratoconus is a corneal degenerative disease characterized by corneal thinning and subsequent development of irregular astigmatism, diminution of vision and loss of best-corrected visual acuity.

Management of keratoconus includes halting disease progression through a corneal strengthening procedure called corneal collagen cross-linking (CXL) which usually results in stabilizing the condition but with no improvement in visual acuity or quality. Intrastromal corneal ring segment (ICRS) implantation is a well-established procedure for the management of moderate keratoconus with a corneal flattening effect that is associated with improvement of visual acuity and reduction of optical aberrations.

The aim of the study is to evaluate and compare the visual, refractive and topographic outcomes of two different femtosecond laser assisted surgical techniques to create a corneal stromal pocket or a tunnel for implantation of ICRS for the management of central keratoconus

Study Design

Study Type:
Interventional
Actual Enrollment :
62 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Pocket Versus Tunnel Intrastromal Corneal Ring Segment Implantation (KeraRing) for the Management of Central Keratoconus
Actual Study Start Date :
Jun 1, 2019
Anticipated Primary Completion Date :
Apr 1, 2023
Anticipated Study Completion Date :
Apr 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Pocket ICRS

Patients in this group are planned to undergo KeraRing implantation through a femtosecond laser-assisted corneal pocket creation for the management of their central keratoconus.

Procedure: Intrastromal corneal ring segment implantation (Pocket)
Patients in this group are planned to undergo ICRS implantation through a femtosecond laser-assisted pocket creation. The device creates an intrastromal corneal pocket of 8-mm diameter and a depth of nearly 80% of the corneal thickness at the thinnest location with a superior tunnel incision at 90° of 4-mm width.

Active Comparator: Tunnel ICRS

Patients in this group are planned to undergo KeraRing implantation through a femtosecond laser-assisted corneal tunnel creation for the management of their central keratoconus.

Procedure: Intrastromal corneal ring segment implantation (Tunnel)
Patients in this group are planned to undergo ICRS implantation through a femtosecond laser-assisted tunnel creation. The device creates an intrastromal tunnel with a depth of nearly 80% of the corneal thickness at the site of implantation. The tunnel inner and outer diameters are at 5 and 6 mm from the corneal center, respectively with the incision located at the steepest keratometry axis.

Outcome Measures

Primary Outcome Measures

  1. Uncorrected distance visual acuity (UDVA) [6 months]

    Uncorrected distance visual acuity measurement using Snellen's Acuity Chart expressed as logMAR notation

  2. Corrected distance visual acuity (CDVA) [6 months]

    Corrected distance visual acuity measurement using Snellen's Acuity Chart expressed as logMAR notation

  3. Postoperative Refraction [6 months]

    Spherical equivalent refraction measured by Topcon Auto-Keratorefractometer

  4. Postoperative keratometry [6 months]

    Postoperative keratometry as measured by Scheimpflug imaging Pentacam

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 35 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  1. Patients with progressive keratoconus with maximum keratometry (Kmax) between 50-65 diopters

  2. Central keratoconus (Keratoconus with steepest corneal point within the central 3 mm zone).

  3. Clear corneal with a minimum pachymetry of 400 μm.

Exclusion Criteria:
  1. Corneal scars

  2. Patients with advanced keratoconus with Kmax > 65 diopters.

  3. Non-central keratoconus (para-central or peripheral keratoconus with steepest corneal point outside the central 3 mm zone).

  4. Previous corneal cross-linking and/or ocular surgery.

  5. Systemic diseases such as diabetes mellitus and autoimmune diseases

Contacts and Locations

Locations

Site City State Country Postal Code
1 Tiba Eye Center Assiut Egypt 71516

Sponsors and Collaborators

  • Assiut University

Investigators

  • Principal Investigator: Mahmoud Abdel-Radi, MD, Assiut University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Mahmoud Abdel-Radi, Principal Investigator, Assiut University
ClinicalTrials.gov Identifier:
NCT05748847
Other Study ID Numbers:
  • PVTICRS
First Posted:
Mar 1, 2023
Last Update Posted:
Mar 1, 2023
Last Verified:
Feb 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Mahmoud Abdel-Radi, Principal Investigator, Assiut University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 1, 2023